Aprea Therapeutics, Inc. Common stock APRE
$0.83
+4.33%
at last close
Financials (TTM)
- Revenue
- $123,296
- Net Income
- $-11,954,827
- Net Margin
- -9696.04%
- Return on Equity
- -28.75%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.21
- Price / Sales
- 71.81
Over the trailing twelve months, Aprea Therapeutics, Inc. Common stock generated revenue of $123,296 and net income of $-11,954,827, a net margin of -9696.04%.
At the last closing price of $0.83, APRE trades at 71.81 times sales, with a market capitalization of $8.85 million.
Key Stats
- Last Close
- $0.83
- Market Cap
- $8.85 million
- 52-Week Range
- $0.55 – $2.22
- Average Volume
- 143K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.